title: [Severe refractory pulmonary hypertension after liver transplantation for hepatitis C liver cirrhosis].
authors.forename: M
authors.initials: M
authors.lastname: Halank
authors.forename: R
authors.initials: R
authors.lastname: Ewert
authors.forename: C
authors.initials: C
authors.lastname: Opitz
authors.forename: H-J
authors.initials: HJ
authors.lastname: Seyfarth
authors.forename: G
authors.initials: G
authors.lastname: Höffken
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage; D004338:Drug Combinations; D011464:Epoprostenol / Q000008:administration & dosage; D006526:Hepatitis C / Q000150:complications / Q000601:surgery*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D016285:Iloprost / Q000008:administration & dosage; D008103:Liver Cirrhosis / Q000209:etiology / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D017211:Treatment Failure; D014665:Vasodilator Agents / Q000008:administration & dosage
chemical_list: D000959:Antihypertensive Agents; D004338:Drug Combinations; D014665:Vasodilator Agents; D011464:Epoprostenol; D016285:Iloprost